BNTC – benitec biopharma inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

BNTC

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

04:37 pm

bntc

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]

Low Report

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]

Report

11/14

04:30 pm

bntc

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

Low Report

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

Report

11/4

08:00 am

bntc

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

Low Report

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

Report

10/18

03:34 pm

bntc

Benitec Biopharma Inc. (NASDAQ: BNTC) had its "overweight" rating re-affirmed by analysts at Piper Sandler.

Low Report

Benitec Biopharma Inc. (NASDAQ: BNTC) had its "overweight" rating re-affirmed by analysts at Piper Sandler.

Report

10/17

11:03 pm

bntc

Benitec Biopharma: OPMD Program Continues To Advance With Catalysts [Seeking Alpha]

Medium Report

Benitec Biopharma: OPMD Program Continues To Advance With Catalysts [Seeking Alpha]

Report

10/16

07:39 am

bntc

Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $35.00 price target on the stock.

Low Report

Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $35.00 price target on the stock.

Report

10/14

08:41 am

bntc

Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $16.00 to $18.00. They now have a "market outperform" rating on the stock.

Medium Report

Benitec Biopharma Inc. (NASDAQ: BNTC) had its price target raised by analysts at JMP Securities from $16.00 to $18.00. They now have a "market outperform" rating on the stock.

Report

10/14

06:00 am

bntc

Benitec Biopharma Announces Updated Investor Webcast Information

Medium Report

Benitec Biopharma Announces Updated Investor Webcast Information

Report

Date

Time

Symbol

Company Name

Action

%Chg

Date

Time

Action

From

Firm

Impact

%Chg

10/16

07:39 am

Initiates

Outperform

Oppenheimer Holdings Inc.

Low

Report

-0.5%

Report

10/16

05:10 am

Initiates

Outperform

Oppenheimer

Report

0.0%

Report

10/16

05:10 am

Initiates

Outperform

Oppenheimer

Report

0.0%

Report

10/14

07:22 am

Maintains

Market Outperform

JMP Securities

Medium

Report

-8.9%

Report

10/14

07:22 am

Maintains

Market Outperform

JMP Securities

Medium

Report

-8.9%

Report

9/30

10:08 am

Reiterates

Market Outperform

JMP Securities

Low

Report

0.7%

Report

9/30

10:08 am

Reiterates

Market Outperform

JMP Securities

Low

Report

0.7%

Report

9/30

09:33 am

Reiterates

Market Outperform

JMP Securities

Low

Report

-0.4%

Report

Date

Time

Symbol

Headline

Impact

11/21

04:25 pm

bntc

Form 4 Benitec Biopharma Inc. For: Nov 19 Filed by: Averill Madison Master Fund, Ltd.

Low Report

Form 4 Benitec Biopharma Inc. For: Nov 19 Filed by: Averill Madison Master Fund, Ltd.

Report

11/18

04:36 pm

bntc

Form SC 13D/A Benitec Biopharma Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC

Medium Report

Form SC 13D/A Benitec Biopharma Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC

Report

11/14

04:56 pm

bntc

Form SCHEDULE 13G Benitec Biopharma Inc. Filed by: Nantahala Capital Management, LLC

Low Report

Form SCHEDULE 13G Benitec Biopharma Inc. Filed by: Nantahala Capital Management, LLC

Report

11/14

04:41 pm

bntc

Form DEFA14A Benitec Biopharma Inc.

Low Report

Form DEFA14A Benitec Biopharma Inc.

Report

11/14

04:38 pm

bntc

Form 8-K Benitec Biopharma Inc. For: Nov 14

Low Report

Form 8-K Benitec Biopharma Inc. For: Nov 14

Report

11/14

04:33 pm

bntc

Form 10-Q Benitec Biopharma Inc. For: Sep 30

Low Report

Form 10-Q Benitec Biopharma Inc. For: Sep 30

Report

11/14

04:32 pm

bntc

Form 8-K Benitec Biopharma Inc. For: Nov 07

Low Report

Form 8-K Benitec Biopharma Inc. For: Nov 07

Report

11/14

01:37 pm

bntc

Form SC 13G/A Benitec Biopharma Inc. Filed by: JANUS HENDERSON GROUP PLC

Neutral Report

Form SC 13G/A Benitec Biopharma Inc. Filed by: JANUS HENDERSON GROUP PLC

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.